Elite Diagnostic Limited (JMSE:ELITE)

Market Cap	583.11M +6.5%
Revenue (ttm)	867.30M +1.6%
Net Income	31.51M -1.6%
EPS	0.09 -1.6%
Shares Out	353.40M
PE Ratio	18.51
Forward PE	n/a
Dividend	0.01 (0.61%)
Ex-Dividend Date	Sep 19, 2025

Volume	100
Open	n/a
Previous Close	1.520
Day's Range	1.650 - 1.650
52-Week Range	1.020 - 2.000
Beta	0.07
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Elite Diagnostic

Elite Diagnostic Limited provides diagnostic imaging services in Jamaica. The company medical imaging services, including CT scan, MRI, x-ray, ultrasound, and fluoroscopy services. It also provides interventional procedures, including angiograms, catheter insertion, aspiration and biopsy, selective hysterosalpingogram and recanalization, lumbar puncture, sclerotherapy, and implant placement services. Elite Diagnostic Limited was incorporated in 2012 and is based in Kingston, Jamaica.

• Industry: Medical Laboratories
• Founded: 2012
• Country: Jamaica
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: ELITE

Financial Performance

In fiscal year 2026, Elite Diagnostic's revenue was 867.30 million, an increase of 1.58% compared to the previous year's 853.82 million. Earnings were 31.51 million, a decrease of -1.62%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 28, 2026

Data Sources Report a data error